Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)
Public ClinicalTrials.gov record NCT03956355. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Efficacy and Safety Study of Tapinarof for the Treatment of Plaque Psoriasis in Adults
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, double-blind, vehicle-controlled Phase 3 study to evaluate the efficacy and safety of topical tapinarof cream, 1% once daily for the treatment of plaque psoriasis in adults. Approximately 500 adult subjects with plaque psoriasis will be randomized 2:1 to receive either tapinarof cream, 1% or matching vehicle cream once daily for 12 weeks.
Study identification
- NCT ID
- NCT03956355
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 510 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 21, 2019 (Actual)
- Primary completion
- May 26, 2020 (Actual)
- Completion
- May 26, 2020 (Actual)
- Last update posted
- Jun 12, 2025
2019 – 2020
United States locations
- U.S. sites
- 44
- U.S. states
- 22
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dermavant Investigative Site | Birmingham | Alabama | 35205 | — |
| Dermavant Investigative Site | Phoenix | Arizona | 85032 | — |
| Dermavant Investigative Site | Hot Springs | Arkansas | 71913 | — |
| Dermavant Investigative Site | Rogers | Arkansas | 72758 | — |
| Dermavant Investigative Site | Anaheim Hills | California | 92807 | — |
| Dermavant Investigative Site | Fresno | California | 93720 | — |
| Dermavant Investigative Site | Los Angeles | California | 90033 | — |
| Dermavant Investigative Site | Northridge | California | 91324 | — |
| Dermavant Investigative Site | San Diego | California | 92123 | — |
| Dermavant Investigative Site | Santa Ana | California | 92701 | — |
| Dermavant Investigative Site | Cromwell | Connecticut | 06416 | — |
| Dermavant Investigative Site | Boca Raton | Florida | 33431 | — |
| Dermavant Investigative Site | Brandon | Florida | 33511 | — |
| Dermavant Investigative Site | Hialeah | Florida | 33016 | — |
| Dermavant Investigative Site | Miramar | Florida | 33027 | — |
| Dermavant Investigative Site | Marietta | Georgia | 30060 | — |
| Dermavant Investigative Site | Evansville | Indiana | 47714 | — |
| Dermavant Investigative Site | Indianapolis | Indiana | 46250 | — |
| Dermavant Investigative Site | New Albany | Indiana | 47150 | — |
| Dermavant Investigative Site | Louisville | Kentucky | 40202 | — |
| Dermavant Investigative Site | Owensboro | Kentucky | 42301 | — |
| Dermavant Investigative Site | Baton Rouge | Louisiana | 70809 | — |
| Dermavant Investigative Site | New Orleans | Louisiana | 70112 | — |
| Dermavant Investigative Site | New Orleans | Louisiana | 70115 | — |
| Dermavant Investigative Site | Boston | Massachusetts | 02115 | — |
| Dermavant Investigative Site | Clarkston | Michigan | 48346 | — |
| Dermavant Investigative Site | Warren | Michigan | 48088 | — |
| Dermavant Investigative Site | Saint Joseph | Missouri | 64506 | — |
| Dermavant Investigative Site | Verona | New Jersey | 07044 | — |
| Dermavant Investigative Site | Kew Gardens | New York | 11374 | — |
| Dermavant Investigative Site | New York | New York | 10029 | — |
| Dermavant Investigative Site | Rochester | New York | 14623 | — |
| Dermavant Investigative Site | Cary | North Carolina | 27518 | — |
| Dermavant Investigative Site | High Point | North Carolina | 27262 | — |
| Dermavant Investigative Site | Norman | Oklahoma | 73071 | — |
| Dermavant Investigative Site | Portland | Oregon | 97210 | — |
| Dermavant Investigative Site | Pittsburgh | Pennsylvania | 15213 | — |
| Dermavant Investigative Site | Johnston | Rhode Island | 02919 | — |
| Dermavant Investigative Site | Arlington | Texas | 76011 | — |
| Dermavant Investigative Site | College Station | Texas | 77802 | — |
| Dermavant Investigative Site | Dripping Springs | Texas | 78620 | — |
| Dermavant Investigative Site | Houston | Texas | 77004 | — |
| Dermavant Investigative Site | San Antonio | Texas | 78213 | — |
| Dermavant Investigative Site | West Jordan | Utah | 84088 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03956355, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 12, 2025 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03956355 live on ClinicalTrials.gov.